ADAPTIVE BIOTECHNOLOGIES CORPORATION
ADAPTIVE BIOTECHNOLOGIES CORPORATION has won 53 federal awards worth $2.0M in total across 3 agencies, with a median award of $25K. See where they win and what those contracts close for, and forecast the price on a solicitation you're competing for.
Recent awards
| Title | Agency | Value | Date |
|---|---|---|---|
| CLONOSEQ TESTING FOR BOSTON AND WEST HAVEN VA HCS | Department Of Veterans Affairs | $35K | 2026-05-29 |
| IMMUNOSEQ MMTCRB SERVICE (DEEP), CATALOG# ISS20001, QTY: 16 | Department Of Health And Human Services | $17K | 2025-05-27 |
| CLONOSEQ TESTING FOR BOSTON AND WEST HAVEN VA HCS | Department Of Veterans Affairs | $95K | 2025-04-08 |
| CLONOSEQ TESTING FOR VISN 1 | Department Of Veterans Affairs | $6K | 2024-12-04 |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION IMMUNOSEQ SEQUENCING SERVICES | Department Of Health And Human Services | $15K | 2024-09-20 |
Questions
How many federal contracts has ADAPTIVE BIOTECHNOLOGIES CORPORATION won?
53 awards on record, worth $2.0M in total across 3 agencies. The median award is $25K.
Which agencies buy from ADAPTIVE BIOTECHNOLOGIES CORPORATION?
Mostly Department Of Health And Human Services, Department Of Veterans Affairs, Department Of Defense.
Is ADAPTIVE BIOTECHNOLOGIES CORPORATION a competitor worth watching?
That depends on your category. This page lists the agencies they win from and their recent awards, so you can see whether they are active in the lanes you bid. AwardCast forecasts the closing price for a specific open solicitation, which is the number that matters when you are bidding against them.
Agencies they win from
Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.
Every forecast is scored against the real award once it becomes public. See the track record.
$49 per report. No subscription, no account needed to see pricing.